Small Business Innovation Research Funding

Key points

  • NIOSH co-sponsors grants for the Small Business Innovation Research (SBIR) program.
  • SBIR helps businesses commercialize innovations from federal research.
  • Interested applicants are encouraged to review the list of NIOSH topics.
Work in office holding a coffee cup looking hopeful

Background

The HHS Small Business Innovation Research (SBIR) program is a partnership among federal agencies. The Centers for Disease Control and Prevention, the Food and Drug Administration, and the National Institutes of Health participate. The goals of the program are to:

  • Stimulate technological innovation
  • Meet federal research and development needs
  • Increase private sector commercialization of innovations developed through federal R&D funding
  • Foster and encourage participation in innovation and entrepreneurship by socially and economically disadvantaged (SDB) persons and women-owned small businesses (WOSB).

NIOSH participates by funding SBIR grants related to occupational safety and health.

Funding by category

R43/44 - Phase I and II

SBIR is a phased program. The main objective Phase I is to establish the technical merit and feasibility of the proposed research and development efforts. Phase II continues the R&D efforts to advance the technology toward ultimate commercialization. At the end of Phase II, small businesses are expected to fully commercialize their product or technology using non-SBIR funds. These funds could be either federal or non-federal.

NIOSH Topics for SBIR‎

Interested applicants are encouraged to review the NIOSH topics identified in SBIR/STTR Program Descriptions and Research Topics Document (pgs 180-184)

Administrative supplements to promote diversity

Additional funds may be awarded as supplements to parent awards. These funds for recruiting and supporting students, post-doctorates, and eligible investigators promote diversity in the research and entrepreneurial workforce. This includes those from groups that have been shown to be underrepresented in health-related research or in the SBIR program.